NLRP3 and rheumatoid arthritis: On the other hand, population studies on RA patients showed that there are mutations of NLRP3 and CARD8 (that consists NLRP3 inflammasome complexes) which are also related to RA susceptibility, disease activity and response rate to TNF-antagonist treatments (152–155).